Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios D Anastasilakis

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Bone|July 28, 2025
Treating osteoporosis with denosumab or bisphosphonates in the long term: facts, uncertainties and assumptions. A narrative review by the clinical action group of the European Calcified Tissue Society (ECTS)Anda Mihaela Naciu, Gaia Tabacco, Andrea Palermo, et al.
JAMA Network Open|September 6, 2024
Conservative Treatments in the Management of Acute Painful Vertebral Compression Fractures: A Systematic Review and Network Meta-AnalysisAssil-Ramin Alimy, Athanasios D Anastasilakis, John J Carey, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|March 30, 2010
Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1Stergios A Polyzos, Athanasios D Anastasilakis, Ioannis Litsas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 23, 2026
Alendronate for 6 or 12 months following denosumab discontinuation in women with postmenopausal osteoporosis: A prospective observational studyPolyzois Makras, Athanasios D Anastasilakis, Andrea Palermo, et al.
Maturitas|November 17, 2023
Nocebo-associated treatment discontinuation with subcutaneous anti-osteoporotic drugs. A systematic review and meta-analysis of placebo-arm dropouts in randomized-controlled trialsMaria P Yavropoulou, Maria-Iosifina Kasdagli, Polyzois Makras, et al.
Metabolism: Clinical and Experimental|September 14, 2016
Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humansAthanasios D Anastasilakis, Stergios A Polyzos, Elpida C Skouvaklidou, et al.
Metabolism: Clinical and Experimental|October 2, 2017
Physiological parameters regulating circulating levels of the IGFBP-4/Stanniocalcin-2/PAPP-A axisGrigorios Panagiotou, Athanasios D Anastasilakis, Georgios Kynigopoulos, et al.
Archives of Osteoporosis|March 17, 2019
The 2018 Guidelines for the diagnosis and treatment of osteoporosis in GreecePolyzois Makras, Athanasios D Anastasilakis, George Antypas, et al.
JBMR Plus|February 22, 2021
Circulating and Tissue Expression Profile of MicroRNAs in Primary Hyperparathyroidism Caused by Sporadic Parathyroid AdenomasMaria P Yavropoulou, Kalliopi Pazaitou-Panayiotou, John G Yovos, et al.
Bone|February 28, 2012
Acute phase response following intravenous zoledronate in postmenopausal women with low bone massAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Bone|July 28, 2025
Treating osteoporosis with denosumab or bisphosphonates in the long term: facts, uncertainties and assumptions. A narrative review by the clinical action group of the European Calcified Tissue Society (ECTS)Anda Mihaela Naciu, Gaia Tabacco, Andrea Palermo, et al.
JAMA Network Open|September 6, 2024
Conservative Treatments in the Management of Acute Painful Vertebral Compression Fractures: A Systematic Review and Network Meta-AnalysisAssil-Ramin Alimy, Athanasios D Anastasilakis, John J Carey, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|March 30, 2010
Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1Stergios A Polyzos, Athanasios D Anastasilakis, Ioannis Litsas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 23, 2026
Alendronate for 6 or 12 months following denosumab discontinuation in women with postmenopausal osteoporosis: A prospective observational studyPolyzois Makras, Athanasios D Anastasilakis, Andrea Palermo, et al.
Maturitas|November 17, 2023
Nocebo-associated treatment discontinuation with subcutaneous anti-osteoporotic drugs. A systematic review and meta-analysis of placebo-arm dropouts in randomized-controlled trialsMaria P Yavropoulou, Maria-Iosifina Kasdagli, Polyzois Makras, et al.
Metabolism: Clinical and Experimental|September 14, 2016
Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humansAthanasios D Anastasilakis, Stergios A Polyzos, Elpida C Skouvaklidou, et al.
Metabolism: Clinical and Experimental|October 2, 2017
Physiological parameters regulating circulating levels of the IGFBP-4/Stanniocalcin-2/PAPP-A axisGrigorios Panagiotou, Athanasios D Anastasilakis, Georgios Kynigopoulos, et al.
Archives of Osteoporosis|March 17, 2019
The 2018 Guidelines for the diagnosis and treatment of osteoporosis in GreecePolyzois Makras, Athanasios D Anastasilakis, George Antypas, et al.
JBMR Plus|February 22, 2021
Circulating and Tissue Expression Profile of MicroRNAs in Primary Hyperparathyroidism Caused by Sporadic Parathyroid AdenomasMaria P Yavropoulou, Kalliopi Pazaitou-Panayiotou, John G Yovos, et al.
Bone|February 28, 2012
Acute phase response following intravenous zoledronate in postmenopausal women with low bone massAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Pageof 16